Good MorningEquity markets were relatively unchanged on Thursday as traders digested the previous day's news. The shift in FOMC policy is promising but may not be the great news equity markets seek. While the Fed has signaled the peak of interest rates and oncoming cuts, the news is already spurring demand for homes and energy, raising the possibility inflation will accelerate again. The rate on the 10-year treasury fell to the lowest level since July during the session, indicating a significant decline in mortgage rates, while the price of oil surged more than 3.5% at the session's peak on demand hope.
The S&P 500 is still in rally mode and will likely end the year higher than it is now. The caution for traders is that the index remains below the all-time high and may be unable to cross the threshold to a new all-time high without another catalyst to drive it. The next significant catalyst is the PCE price index due on December 22nd, just in time to usher in the Santa Claus Rally if it confirms cooling inflation. Featured: Get These Top Performing Stocks At A Discount Right Now! (Darwin) |
Stocks | |
The reality is that nothing lasts forever, including your home and everything in it. Just when you think all is quiet on the home repair front, your water heater will go out. Or your kids will throw a baseball through the living room window. Or an episode of Fixer Upper will spark a desire to rede... Read the Full Story |
|
From Our PartnersThere is a recession-proof company that is poised to grow in the coming years. Our research team has given them our highest score as a solid addition to any portfolio.
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
| | Download The Full Report Here for Free |
|
Markets | |
If the financial markets were an orchestra, consumer discretionary would be the melody — it's not always the most dominant tune. Still, its fluctuations and rhythms often guide the mood and tempo of the overall market performance. From luxury goods to leisurely pursuits, consumer discretiona... Read the Full Story |
|
Markets | | It's been a great year for stock markets around the world.Wall Street's rally has been front and center, with the U.S. stock market the world's largest and its clear leader in performance in recent years. The S&P 500 is on track to return more than 20% for the third time in the last five years, ... Read the Full Story |
|
From Our PartnersThere is a recession-proof company that is poised to grow in the coming years. Our research team has given them our highest score as a solid addition to any portfolio.
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
| Download The Full Report Here for Free |
|
Markets | | Wall Street drifted through mixed trading on Friday to put a quiet end to another rocking week.The S&P 500 finished nearly unchanged for the day, down 0.36, or less than 0.1%, at 4,719.19. But it’s still hanging within 1.6% of its all-time high set early last year, and it closed out a seventh st... Read the Full Story |
|
Markets | |
Jabil, Inc. (NASDAQ: JBL) is a double-narrative, and investors will like both. On the one hand, it’s suffering from end-market weakness, impacting the outlook for top-line growth. That has put some pressure on the market and caused the stock price to be corrected following the FQ4 release in... Read the Full Story |
|
From Our PartnersRising interest rates... Skyrocketing inflation... Exploding debt... A looming recession... It's no wonder Americans are becoming more and more concerned about their savings and investments. That's why Ben Stein wrote his newest report... This FREE REPORT shows YOU how you could protect your retirement savings before it's too late. Request your free report today and learn how you could protect everything you've worked for! | | Request Your FREE Ben Stein Report Today! |
|
Markets | |
Choosing where to stow away your hard-earned money can feel overwhelming at times.
Should you venture into the dynamic growth potential of an individual retirement account (IRA), park your money in the reliable corner of a certificate of deposit (CD) or perhaps find a middle ground with a m... Read the Full Story |
|
Markets | |
Ford Motor Co. (NYSE: F) just threw a wrench into the machinery of automotive stocks, when it comes to EV manufacturing.
Anytime you’re driving around, noticing the cars on the road, it’s easy to make two observations about EV adoption.
First, it’s growing. There are more... Read the Full Story |
|
Markets | | The painful economic steps that Argentina's new president, Javier Milei, announced this week sound draconian: Slashing the currency's value in half. Reducing aid to provincial governments. Suspending public works. Cutting subsidies for gas and electricity. Raising some taxes. Yet the South American ... Read the Full Story |
|
Markets | | The Bank of England kept borrowing rates unchanged Thursday despite mounting worries over the state of the British economy, and it showed little sign that it is contemplating cutting them anytime soon — unlike the U.S. Federal Reserve.The central bank left its main interest rate at a 15-year high of... Read the Full Story |
|
Markets | | The European Central Bank kept its key interest rate at a record high Thursday and said it will leave it there as long as needed to battle back inflation, signaling that cuts are not around the corner despite expectations it will act next year to support the shrinking economy.It follows similar deci... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. | View Today's Stock Pick |
|